Table of Contents 

INFOSPACE, INC. 

CONSOLIDATED STATEMENTS OF CASH FLOWS 

(in thousands) 

Years Ended December 31, 

2001 

2000 

1999 

OPERATING ACTIVITIES: 

Net loss 

$  (502,079 )    

$  (282,412 )    

$  (240,133 ) 

Adjustments to reconcile net loss to net cash provided (used) by operating activities: 

Depreciation and amortization 

256,067      

183,526      

47,707   

Impairment of intangibles 

107,729      

8,952      

Warrant and stock related revenue 

(14,024 )    

(22,075 )    

(3,168 ) 

Preferred stock dividend 

159,931   

Warrants expense 

815      

3,703      

18,468   

Stock based compensation expense 

3,402      

1,713      

2,865   

Minority interest in venture fund 

(17 )    

3,171      

Loss on disposal of fixed assets 

323      

324      

13   

Noncash services exchanged 

1,414   

Noncash loss on investments 

108,157      

858      

26   

Bad debt expense 

4,395      

7,376      

1,326   

Tax benefit from stock options 

4,525   

Non cash restructuring 

12,283      

Write off of in process research and development 

600      

80,100      

9,200   

Noncash other charges 

9,352      

Business acquisition costs 

43,898      

4,374   

Cumulative effect of change in accounting principle 

3,171      

2,056      

Cash provided (used) by changes in operating assets and liabilities, net of assets acquired in business combinations: 

Accounts receivable 

12,887      

(28,762 )    

(12,053 ) 

Other receivable 

(16,947 )    

7,832      

(14,626 ) 

Prepaid expenses and other current assets 

4,161      

261      

(9,267 ) 

Other long term assets 

2,394      

(782 )    

(91 ) 

Accounts payable 

3,713      

2,495      

860   

Accrued expenses and other liabilities 

(19,929 )    

(14,572 )    

10,135   

Deferred revenue 

(17,426 )    

19,116      

6,683   

Net cash provided (used) by operating activities 

(40,973 )    

16,778      

(11,811 ) 

INVESTING ACTIVITIES: 

Business and asset acquisitions, net of cash acquired 

(16,586 )    

(45,680 )    

(52,577 ) 

Minority interest contribution (purchase) in venture fund 

(16,365 )    

16,365      

Asset sale 

2,707      

Purchase of intangible asset 

(110 ) 

Notes receivable 

100      

(20,850 )    

Purchase of other investments 

(10,971 )    

(41,270 )    

(13,202 ) 

Purchase of property and equipment 

(12,007 )    

(44,370 )    

(9,079 ) 

Short and long term investments 

75,005      

130,244      

(348,299 ) 

Net cash provided (used) by investing activities 

21,883      

(5,561 )    

(423,267 ) 

FINANCING ACTIVITIES: 

Proceeds from stock options and warrants 

8,036      

37,471      

22,284   

Proceeds from issuance of ESPP shares 

1,563      

1,512      

394   

Proceeds (payments) from issuance of common stock, net 

(24 )    

476,042   

Payment for repurchase of common stock 

(22,786 )    

Payments on debt assumed from acquisitions 

(3,075 )    

(613 )    

(460 ) 

Net cash provided (used) by financing activities 

(16,262 )    

38,346      

498,260   

Net increase (decrease) in cash and cash equivalents 

(35,352 )    

49,563      

63,182   

Cash and cash equivalents, beginning of period 

153,913      

104,350      

41,168   

Cash and cash equivalents, end of period 

$  118,561      

$  153,913      

$  104,350   

SUPPLEMENTAL DISCLOSURE OF NONCASH FINANCING AND INVESTING 

ACTIVITIES: 

Acquisitions from purchase transactions: 

Stock issued 

$ 

92,473      

$  572,938      

$  253,137   

Net assets acquired 

(2,731 )    

(21,877 )    

(150 ) 

Property and equipment acquired under equipment financing and capital lease obligations 

308   

Common stock received for employee note receivable 

410      

Issuance of warrants and options for deferred services and abandoned financing 

2,665   

Compensation expense for Prio warrants 

2,888      

17,652   

Stock issued in exchange transaction 

169   

Stock issued for retirement of debentures 

170   

Preferred stock dividend 

159,931   

Interest paid 

132   

See notes to consolidated financial statements.